Neogen Delivers Q1 Revenue of $222.8M and $0.08 EPS, Exceeding Consensus
Question
Neogen Delivers Q1 Revenue of $222.8M and $0.08 EPS, Exceeding Consensus
Direct answer
Operating leverage on 6.5% top-line growth drives a 60% adjusted EPS beat, triggering upward revisions to NEOG full-year gross margin and earnings multiples. — bullish pressure on NEOG via earnings beat flow-through to forward FY2026 EPS consensus revisions.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-07
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “Neogen Delivers Q1 Revenue of $222.8M and $0.08 EPS, Exceeding Consensus”, revision 1, evidence through 2026-10-07. https://marketontology.com/catalysts/2026-10-07/neogen-delivers-q1-revenue-of-222-8m-and-0-08-eps-exceeding-consensus-2b670d
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| NEOG | ▲Bull | 1–5 days | earnings beat flow-through to forward FY2026 EPS consensus revisions | 51 |
Neogen Delivers Q1 Revenue of $222.8M and $0.08 EPS, Exceeding Consensus
Operating leverage on 6.5% top-line growth drives a 60% adjusted EPS beat, triggering upward revisions to NEOG full-year gross margin and earnings multiples. — bullish pressure on NEOG via earnings beat flow-through to forward FY2026 EPS consensus revisions.
Q1 EPS $0.08 vs $0.05 estimate; revenue $222.8M vs $208.09M estimate
- SourceQ1 EPS $0.08 vs $0.05 estimate; revenue $222.8M vs $208.09M estimate
- TransmissionOperating leverage on 6.5% top-line growth drives a 60% adjusted EPS beat, triggering upward revisions to NEOG full-year gross margin and earnings multiples.
- SummaryNeogen reports Q1 EPS of $0.08, topping the $0.05 consensus estimate. Revenue grew 6.5% YoY to $222.8 million, beating estimates by 7.07%. Performance driven by food safety and animal genomics demand.
- NEOGDirect directional exposure
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- Sector rotation or peer guidance may override single-name reaction
- NEOG closes below pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- NEOG price vs. pre-event level
- NEOG volume vs. 20-day average
- Sector ETF read-through
- Options implied volatility crush
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| NEOG | Bullishagreed | 11.68 2026-10-07 | +0.26% | Pending | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
Sources
- Neogen Q1 Earnings: Key Metrics · earnings_report · 2026-10-06
Related catalysts
- 2026-10-07Neogen posts Q1 earnings beat with revenue up 6.5% YoY to $222.8M and EPS of $0.08NEOG+0.26%
- 2026-10-07Neogen Q1 Revenue Rises 6.5% to $222.8M, Surpassing Consensus EPS EstimatesNEOG+0.26%
- 2026-10-07Neogen Delivers Q1 Revenue of $222.8M and $0.08 EPS, Exceeding ConsensusNEOG+0.26%
- 2026-10-07Neogen beats Q1 estimates with 60% EPS surprise on Food Safety expansionNEOG+0.26%
- 2026-10-07Neogen Q1 EPS Tops Consensus by 60% as Revenue Reaches $222.8MNEOG+0.26%
- 2026-10-07Neogen Reports Q1 Earnings Beat with 6.5% Revenue Growth to $222.8MNEOG+0.26%
- 2026-10-07Neogen Q1 EPS Tops Consensus by 60% as Revenue Reaches $222.8MNEOG+0.26%
- 2026-10-07Neogen posts Q1 earnings beat with revenue up 6.5% YoY to $222.8M and EPS of $0.08NEOG+0.26%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.